Valamehr Bahram Insider Trading Activity

Average Profitability
<0.0001%
Insider Buys Quantity
0
Insider Buys Sum
$0
Insider Sells Quantity
18
Insider Sells Sum
$17.05M

Insider Activity of Valamehr Bahram

According to the SEC Form 4 filings, Valamehr Bahram, being in a position of

  1. President and CEO at Fate Therapeutics, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 78083 shares for $168,140,
    over all time since 2019-10-15, has bought 0 shares, and sold 394852 shares for $17.23M.

Biography of Valamehr Bahram

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
 $000
Sells
 $168,1403100

Comparison of Insiders on Amount of Buys and Sells

2026-08-04SaleFate Therapeutics, Inc.
FATE
President and CEO
43,947
0.0361%
$2.46$108,101-7.39%
2026-05-20SaleFate Therapeutics, Inc.
FATE
President and CEO
28,946
0.0254%
$1.88$54,482+30.98%
2026-01-09SaleFate Therapeutics, Inc.
FATE
President and CEO
5,190
0.0046%
$1.07$5,557+96.19%
2025-08-04SaleFate Therapeutics, Inc.
FATE
President and CEO
14,466
0.0126%
$1.06$15,396+16.04%
2025-01-10SaleFate Therapeutics, Inc.
FATE
President and CEO
8,705
0.008%
$1.54$13,406-23.81%
2024-01-09SaleFate Therapeutics, Inc.
FATE
Chief R&D Officer
11,271
0.0114%
$4.38$49,367-14.74%
2023-01-10SaleFate Therapeutics, Inc.
FATE
Chief R&D Officer
10,917
0.0106%
$5.24$57,205-13.84%
2022-07-07SaleFate Therapeutics, Inc.
FATE
Chief R&D Officer
17,158
0.0173%
$30.23$518,686-68.12%
2022-07-06SaleFate Therapeutics, Inc.
FATE
Chief R&D Officer
7,842
0.0085%
$30.07$235,809-65.07%
2022-03-14SaleFate Therapeutics, Inc.
FATE
Chief R&D Officer
2,960
0.0034%
$33.30$98,568-24.5%
2022-01-11SaleFate Therapeutics, Inc.
FATE
Chief R&D Officer
4,570
0.0048%
$48.50$221,655-43.63%
2022-01-10SaleFate Therapeutics, Inc.
FATE
Chief R&D Officer
5,596
0.0055%
$46.38$259,558-45.37%
2021-12-13SaleFate Therapeutics, Inc.
FATE
Chief R&D Officer
25,000
0.0257%
$47.66$1.19M-39.14%
2021-09-13SaleFate Therapeutics, Inc.
FATE
Chief Development Officer
25,000
0.0264%
$66.29$1.66M-44.34%
2021-06-14SaleFate Therapeutics, Inc.
FATE
Chief Development Officer
25,000
0.0263%
$89.32$2.23M-40.2%
2021-03-15SaleFate Therapeutics, Inc.
FATE
Chief Development Officer
25,000
0.0266%
$92.35$2.31M-26.56%
2021-01-11SaleFate Therapeutics, Inc.
FATE
Chief Development Officer
3,254
0.0034%
$110.81$360,588-31.03%
2021-01-08SaleFate Therapeutics, Inc.
FATE
Chief Development Officer
6,230
0.0067%
$117.10$729,552-33.06%
2020-12-14SaleFate Therapeutics, Inc.
FATE
Chief Development Officer
50,000
0.0581%
$97.78$4.89M-15.66%
2020-09-14SaleFate Therapeutics, Inc.
FATE
Chief Development Officer
50,000
0.0558%
$36.31$1.82M+120.49%
Total: 22
Company
About Prismo.proIdeasArticlesPrivacy PolicyTerms of ServiceContact Us
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksStock NewsInsider RatioList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.